PubRank
Search
About
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
Clinical Trial ID NCT01525927
PubWeight™ 4.25
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT01525927
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Case-control study of human papillomavirus and oropharyngeal cancer.
N Engl J Med
2007
16.39
2
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
J Natl Cancer Inst
2000
14.43
3
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
J Natl Cancer Inst
2008
12.77
4
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
N Engl J Med
2007
10.06
5
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.
J Clin Oncol
2008
7.97
6
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
N Engl J Med
2007
7.05
7
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
N Engl J Med
2001
6.33
8
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
J Natl Cancer Inst
2003
6.28
9
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
J Natl Cancer Inst
2007
4.55
10
Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?
Cancer
2007
4.20
11
Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years.
Cancer
2005
3.79
12
Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.
Int J Cancer
2005
3.27
13
Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.
Int J Cancer
2008
2.62
14
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis.
Clin Cancer Res
2003
1.55
15
Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
Cancer
2004
1.43
16
Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
J Clin Oncol
1996
0.99
17
Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck.
Int J Radiat Oncol Biol Phys
2014
0.97
18
Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.
Otolaryngol Clin North Am
2013
0.94
19
Is radiation dose reduction the right answer for HPV-positive head and neck cancer?
Oral Oncol
2013
0.91
20
HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratification.
Sensors (Basel)
2012
0.82
21
De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review.
Oncol Lett
2015
0.75
Next 100